These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 3159522

  • 1. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK, Holme E, Hamilton E, Whaley K.
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [Abstract] [Full Text] [Related]

  • 2. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Control of immune complexes by the classical pathway.
    Whaley K, Ahmed AE.
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
    Whaley K, Thompson RA.
    Immunology; 1978 Dec; 35(6):1045-9. PubMed ID: 83964
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
    Fischer E, Ouaissi MA, Velge P, Cornette J, Kazatchkine MD.
    Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
    [Abstract] [Full Text] [Related]

  • 14. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

  • 15. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 01; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 16. [The alternative complement pathway].
    Jouvin MH, Kazatchkine M.
    Pathol Biol (Paris); 1983 Dec 01; 31(10):839-46. PubMed ID: 6230588
    [Abstract] [Full Text] [Related]

  • 17. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A, Whaley K.
    J Rheumatol; 1980 Dec 01; 7(4):453-60. PubMed ID: 6158571
    [Abstract] [Full Text] [Related]

  • 18. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP, Schreiber RD, Cooper NR.
    J Immunol; 1983 Mar 01; 130(3):1317-22. PubMed ID: 6822737
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.